Convalescent plasma from Norwegian blood donors to treat COVID-19.

Background: At the start of the pandemic, the Norwegian Directorate of Health and Norwegian blood banks initiated the production of COVID-19 convalescent plasma within the framework of clinical studies. In this article we describe the blood donors who participated.

Material And Method: Blood donors who had recovered from COVID-19 were recruited to donate single donor plasma for the purpose of patient treatment.

Can inter-professional simulation training influence the frequency of blood transfusions after birth?

Objective: To investigate whether inter-professional simulation training influenced the rate of red blood cell (RBC) transfusions after birth.

Design: Two cohorts were compared retrospectively using a pre-post design.

Setting: Norwegian university hospital with 4800 deliveries annually.